C-YGSXMagnitude Biosciences
C. elegans, whole-organism HTS, automated imaging
research tools
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-YGSX
C-YGSXC-YGSXC. elegans, whole-organism HTS, automated imaging
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Magnitude Biosciences C. elegans, whole-organism HTS, automated imaging
Magnitude Biosciences offers contract lab services using customised C. elegans studies to generate reproducible research data. Its VivoScan platform is described as a high-throughput screening platform for whole-organism screening at scale. The site lists service areas including ageing and longevity, neurodegeneration, muscle health, gut health, cognition, disease modelling, weight management, and toxicity.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Magnitude Biosciences — Early mechanism · Lower middle. Derived deterministically from 6 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (4 programs at preclinical).…
Source: Deterministic